AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsSign up free
🇿🇦

Imatinib Mesilate Equivalent To Imatinib in South Africa

10 products registered with SAHPRA — 8 active

Brand / ProductReg. No.HolderStatusExpires
NAZZEC 40046/26/0370Sandoz South Africa (Pty) Ltdsuspended30 Nov 2023
NAZZEC 10046/26/0369Sandoz South Africa (Pty) Ltdsuspended30 Nov 2023
SUNMATIN 10044/26/0886Ranbaxy Pharmaceutical (Pty) Ltdactive12 May 2018
GLEEVEC38/34/0143Novartis South Africa (Pty) Ltdactive1 Jan 1900
VATIVIO 40046/26/0368Novartis South Africa (Pty) Ltdactive1 Jan 1900
GLEEVEC 40038/34/0144Novartis South Africa (Pty) Ltdactive1 Jan 1900
IMATINIB 100 mg ADCO53/34/0187Adcock Ingram Critical Care (Pty) Ltdactive1 Jan 1900
VATIVIO FC46/26/0367Novartis South Africa (Pty) Ltdactive1 Jan 1900
IMAVEC42/34/0496Cipla Medpro (Pty) Ltdactive1 Jan 1900
IMATINIB 400 mg ADCO53/34/0188Adcock Ingram Critical Care (Pty) Ltdactive1 Jan 1900

Imatinib Mesilate Equivalent To Imatinib — SAHPRA Registration Details

SAHPRA (South Africa) has 10 registered products containing Imatinib Mesilate Equivalent To Imatinib, of which 8 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.

Track Imatinib Mesilate Equivalent To Imatinib registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.